1. Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. Issue 8 (August 2022) Authors: Ochoa-Azze, Rolando; Chang-Monteagudo, Arturo; Climent-Ruiz, Yanet; Macías-Abraham, Consuelo; Valenzuela-Silva, Carmen; de los Ángeles García-García, María; Jerez-Barceló, Yanet; Triana-Marrero, Yenisey; Ruiz-Villegas, Laura; Dairon Rodríguez-Prieto, Luis; Guerra-Chaviano, Pedro Pablo; Sánchez-Ra... Journal: Lancet Issue: Volume 10:Issue 8(2022) Page Start: 785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗